[
  {
    "ts": null,
    "headline": "How The BLSH Portfolio Buys Low And Sells High, Consistently",
    "summary": "The BLSH strategy systematically buys blue-chip stocks at undervalued prices and sells partial positions at overvalued levels. Learn more about the strategy here.",
    "url": "https://finnhub.io/api/news?id=da9f4c876d8f46ad218f622289f0a249ade8eac2f56f6ee313e2293c6632ad29",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748766600,
      "headline": "How The BLSH Portfolio Buys Low And Sells High, Consistently",
      "id": 134927246,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/536134845/image_536134845.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The BLSH strategy systematically buys blue-chip stocks at undervalued prices and sells partial positions at overvalued levels. Learn more about the strategy here.",
      "url": "https://finnhub.io/api/news?id=da9f4c876d8f46ad218f622289f0a249ade8eac2f56f6ee313e2293c6632ad29"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Unveils First-In-Human Results For Pasritamig, Showing Early Anti-Tumor Activity In Prostate Cancer",
    "summary": "Johnson & Johnson: * JOHNSON & JOHNSON UNVEILS FIRST-IN-HUMAN RESULTS FORPASRITAMIG,SHOWING EARLY ANTI-TUMOR ACTIVITY IN PROSTATE CANCER * JOHNSON & JOHNSON - PASRITAMIG...",
    "url": "https://finnhub.io/api/news?id=01e94ee1e3331ef990d928eeaa9dc177c1dab02b9da4162f15606f1b847136e6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748765588,
      "headline": "Johnson & Johnson Unveils First-In-Human Results For Pasritamig, Showing Early Anti-Tumor Activity In Prostate Cancer",
      "id": 134927159,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson: * JOHNSON & JOHNSON UNVEILS FIRST-IN-HUMAN RESULTS FORPASRITAMIG,SHOWING EARLY ANTI-TUMOR ACTIVITY IN PROSTATE CANCER * JOHNSON & JOHNSON - PASRITAMIG...",
      "url": "https://finnhub.io/api/news?id=01e94ee1e3331ef990d928eeaa9dc177c1dab02b9da4162f15606f1b847136e6"
    }
  }
]